APPLICATION
NDA217906
TYPE
NDA
ORIGINAL APPROVAL
2025-02-07
LATEST ACTION
2025-02-07
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
EMBLAVEO · ReferencePrescription
AVIBACTAM SODIUM EQ 0.5GM BASE/VIAL, AZTREONAM 1.5GM/VIAL · POWDER · INTRAVENOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.